Aquaporins (AQPs) are water channels found widely in bacteria, plants, animals, and humans. There are presently 13 known types of aquaporins in humans (AQP0 to AQP12), which are expressed in various organs. 1) In the kidney, several members of the AQP family are expressed, which are responsible for regulating water volume in the body. Especially in the renal collecting duct, AQP2, which is expressed on the luminal membranes of principal cells, and AQP3 and AQP4, which are expressed on the basolateral membranes of principal cells, are involved in urine concentration by inducing the re-absorption of water from the luminal side to the basolateral side.
Snow Brand Milk Products Co., Ltd. (Tokyo, Japan). An RNeasy mini kit was purchased from Qiagen Inc. (Valencia, CA, U.S.A.). A high capacity cDNA reverse transcription kit was purchased from Applied Biosystems (Foster City, CA, U.S.A.). iQ SYBR green supermix and RNase-free water were purchased from Bio-Rad Laboratories (Hercules, CA, U.S.A.). Tris EDTA buffer solution (TE buffer; pH 8.0) was purchased from Nacalai Tesque (Kyoto, Japan). Primers were purchased from Invitrogen (Tokyo, Japan). All other reagents were of the highest commercially available grade.
Development of STZ Model Mice ICR mice (six weeks old) were purchased from Sankyo Labo Service (Tokyo, Japan). Each mouse was kept at room temperature (24Ϯ1°C) and 55Ϯ10% humidity in a 12-h light cycle (artificial illumination: 08:00-20:00). The present study was conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals, as adopted by the Committee on Animal Research of Hoshi University.
After a 12-h fast, mice were given a single intravenous administration of 150 mg/kg STZ dissolved in 0.05 M citrate buffer (pH 4.5). After two weeks of administration, blood samples were taken from the eyeground. Mice with greater than 500 mg/dl of plasma glucose were used in this study. Normal mice were given a single intravenous injection of citrate buffer.
Li 2 CO 3 Treatment Normal mice and STZ treated mice were provided with control chow, chow containing 0.1% or 0.2% Li 2 CO 3 for 10 d, ad libitum. After 7 d of administration, water intake and 24-h urine volume were measured. Twentyfour-hour urine volume was measured from 11:00 to the same time on the following day using a metabolic cage (Natsume Seisakusho Co., Ltd., Tokyo, Japan). After 10 d, animals were anesthetised under diethyl ether and a blood sample was collected from the abdominal vena cava using heparin. The kidney was removed, frozen in liquid nitrogen, and stored at Ϫ80°C.
Blood and Urine Analysis The blood samples were centrifuged (1000ϫg for 15 min at 4°C), and plasma was stored at Ϫ80°C until assays were performed. The urine samples were centrifuged (1000ϫg for 15 min at 4°C). The plasma glucose concentration and urine glucose concentration were enzymatically quantified using a Glucose CII-Test Wako (Wako Pure Chemical Industries, Ltd.). The plasma creatinine and urine creatinine concentrations were determined using a Creatinine assay kit (BioVision, Inc., Mountain View, CA, U.S.A.). Creatinine clearance (C cr ), as an indicator of glomerular filtration rate, was calculated via C cr ϭ(C u /C p )ϫV, where C u is the concentration of creatinine in the urine, C p is the concentration of creatinine in plasma, and V is the urine flow rate in millilitres per minute.
12)
RNA Preparation from Tissue Samples RNA was extracted from the outer medulla and inner medulla isolated from the kidney using the RNeasy mini kit, respectively. RNA extraction was performed according to the kit protocol. The resulting solution was diluted 25-fold with TE buffer solution, and the RNA purity and concentration (mg/ml) were calculated by measuring the absorbance at 260 and 280 nm using a spectrophotometer (U-2800; Hitachi High Technologies, Tokyo, Japan).
Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) A high-capacity cDNA synthesis kit was used to synthesise cDNA from 1 mg of RNA. TE buffer solution was used to dilute the cDNA 20-fold to prepare a cDNA TE buffer solution. The expression of target genes was detected by preparing the primers listed in Table 1 and performing real-time RT-PCR. To each well of a 96-well PCR plate, 25 ml of iQ SYBR green supermix, 3 ml of forward primer for the target gene (5 pmol/ml), 3 ml of reverse primer (5 pmol/ml), 4 ml of cDNA TE buffer solution, and 15 ml of RNase-free water were added. The denaturation temperature was set at 95°C for 15 s, the annealing temperature was 56°C for 30 s, and the elongation temperature was 72°C for 30 s. The fluorescence intensity of the amplification process was monitored using the My iQ TM single-color, realtime RT-PCR detection system (Bio-Rad Laboratories). The mRNA levels were normalised against 18S rRNA.
Preparation of the Membrane Fraction for Immunoblotting Fractionation of the kidney tissue was performed using the method of Marples et al. 13) with slight modification. The inner medulla and cortex were separated from the kidney and homogenised (1250 rpm, 5 strokes) in dissecting buffer (0.3 M sucrose, 25 mM imidazole, 1 mM EDTA, 8.5 mM leupeptin, 1 mM PMSF; pH 7.2) on ice. The homogenate was centrifuged (4000ϫg for 15 min at 4°C). The resulting supernatant was centrifuged (17000ϫg for 30 min at 4°C) and the supernatant was removed. Dissecting buffer was added to the precipitate and homogenised using an ultrasonic homogeniser (UH-50, SMT Co., Ltd., Tokyo, Japan) to yield the plasma membrane-enriched fraction.
Electrophoresis and Immunoblotting The protein concentration was measured by the method of Lowry et al., 14) and BSA was used to generate a standard curve.
Electrophoresis was performed using the Laemmli method. 15) Four micrograms of protein were diluted 2-fold in loading buffer (84 mM Tris, 20% glycerol, 0.004% bromophenol blue, 4.6% SDS, 10% 2-mercaptoethanol; pH 6.3), boiled for 5 min and separated on a 7.5% polyacrylamide gel. After electrophoresis, proteins were transferred to a PVDF TauT  NM_17208  GTTCTGGGAGCGCAACGT  ACCGAACACCCTTCCAGATG  NKCC2  U20974  GTCTCGGTGTGATTATCATCGG  ATCCGTTTGTGGCGATAGCAG  UT-A1  AF366052  AAGGAGATGTCTGACAGCAACA  GGGCTGGGTGTGTATCCTG  GLUT2  NM_031197  CTGGAGCCCTCTTGATGGGA  CCAGTCCTGAAATTAGCCCACA  SGLT2  NM_133254  TGAGTGGAATGCGCTCTTCG  CTTGCGGAGGTACTGAGGC  18S rRNA  X00686  GTCTGTGATGCCCTTAGATG  AGCTTATGACCCGCACTTAC membrane using the CompactBLOT system (AE-7500, Atto Corp., Tokyo, Japan). Membranes were blocked for 1 h in 1.0% skim milk and incubated with rabbit anti-AQP1 (1 : 500), rabbit anti-AQP2 (1 : 1000), rabbit anti-AQP3 (1 : 500), or rabbit anti-AQP4 (1 : 500) for 1 h at room temperature. Membranes were then washed in TBS-Tween (20 mM Tris-HCl, 137 mM NaCl, 0.1% Tween 20; pH 7.6) and incubated with donkey anti-rabbit immunoglobulin G (IgG) (whole molecule) horse radish peroxidase conjugate (AQP1 and AQP3; 1 : 2000, AQP2 and AQP4; 1 : 5000) for 1 h at room temperature. Membranes were then washed and developed using the ECL plus detection reagents. Bands were visualised using a Lumino-image analyzer (LAS-3000 mini; Fuji Film, Tokyo, Japan). Statistical Analysis Numerical data were expressed as meansϮstandard deviation. The significance of differences was examined by the ANOVA method, followed by the Tukey test. Results with p values Ͻ0.05 were considered significant. The urine volume of the normal mice was approximately 1 ml/d, which increased to 7 ml/d after Li 2 CO 3 treatment. The urine volume of the STZ mice was approximately 36 ml/d. In the Li 2 CO 3 -treated STZ mice, the urine volume increased significantly compared to that in the STZ mice. Specifically, the urine volume in the 0.2% Li 2 CO 3 -treated STZ group was 70 ml/d, which was approximately twice the volume in the STZ group (Fig. 1C) .
RESULTS

Effects of Li
Water intake in the normal mice was approximately 2 ml/d, which increased approximately six fold after Li 2 CO 3 treatment. Water intake in the STZ mice was 50 ml/d. Water intake in the Li 2 CO 3 -treated STZ mice increased significantly relative to that in the STZ group. In particular, water intake in the 0.2% Li 2 CO 3 -treated STZ group was 80 ml/d, which was approximately 1.6 times higher than that in the STZ group (Fig. 1D) .
Creatinine clearance (C cr ) in the normal mice was approximately 0.3 ml/min, which did not change after Li 2 CO 3 treatment. C cr in either the STZ mice or the Li 2 CO 3 -treated STZ mice was nearly the same as that in the normal mice (Fig.  1E) .
Effects of Li 2 CO 3 on Osmoregulatory Genes To investigate the osmotic pressure of urine in the collecting tubules, the expression levels of the osmoregulatory genes were measured. [16] [17] [18] [19] The mRNA expression level of sodium myoinositol transporter (SMIT) in STZ mice was twice as high as that of normal mice. Li 2 CO 3 did not exert any effect on the mRNA expression levels of SMIT in either STZ mice or normal mice (Fig. 2A) . The mRNA expression levels of taurine transporter (TauT) showed the same tendency as that of SMIT (Fig. 2B) .
Effects of Li 2 CO 3 on the Expression Levels of Sodium Transporter, Urea Transporter, and Glucose Transporter in the Kidneys The mRNA expression levels of sodium transporter (Na-K-Cl cotransporter 2; NKCC2), urea transporter (urea transporter A1; UT-A1), and glucose transporters (glucose transporter 2; GLUT2, sodium/glucose co- transporter 2; SGLT2) in the renal inner medulla, where the collecting tubules were dominantly present, were measured (Fig. 3) .
The mRNA expression level of NKCC2 in STZ mice was nearly equal to that of the normal mice. Li 2 CO 3 treatment did not exert any changes in the mRNA expression levels of NKCC2 in both normal and STZ mice.
The mRNA expression levels of UT-A1, GLUT2, and SGLT2 of STZ mice were significantly higher than those of normal mice. Li 2 CO 3 treatment significantly decreased the expression levels of these mRNAs in both normal and STZ mice.
Effect of Li 2 CO 3 on the Expression Levels of AQP1, AQP2, AQP3, and AQP4 in the Kidneys The expression level of AQP1 in the plasma membrane fraction of the renal cortex, where the proximal tubules were dominantly present, was determined by the Western blotting method. AQP1 was identified as two bands (Fig. 4A) . One of these appeared at around 25 kDa and represented the deglycosylated form of AQP1, while the other appeared at around 35-45 kDa and represented a glycosylated form of AQP1. This glycosylation is associated with the stability and intracellular translocation of AQP, 20, 21) but has no effect on water permeability. 22) Therefore, in the present study, the AQP1 protein expression level was analysed using the sum of the intensities of these two bands. The expression level of AQP1 in STZ mice was nearly equal to that of normal mice. Li 2 CO 3 treatment did not exert any changes on the expression level of AQP1 in either normal or STZ mice. AQP2 was identified as two bands in the Western blot of the plasma membrane fraction of the renal inner medulla, where the collecting tubules were dominantly present. One of these bands appeared at around 29 kDa, while the other appeared at around 40-50 kDa (Fig. 4B) . The sum of the intensities of these two bands in STZ mice was approximately 2.7 times higher than that of normal mice. Li 2 CO 3 treatment significantly decreased the expression levels of AQP2 in both normal and STZ mice.
AQP3 was identified as two bands in the Western blot of the plasma membrane fraction of the renal inner medulla, where the collecting tubules were dominantly present. One of these bands appeared at around 27 kDa and represented a deglycosylated form of AQP3, while the other band appeared at around 33-40 kDa and represented a glycosylated form of APQ3 (Fig. 4C) . The expression level of AQP3 in STZ mice was significantly higher than that of normal mice. Li 2 CO 3 treatment significantly decreased the expression levels of AQP3 in both normal and STZ mice.
AQP4 was identified as a single band, which appeared at around 33 kDa, in the Western blot of the plasma membrane fraction of the renal inner medulla, where the collecting tubules were dominantly present (Fig. 4D) . The expression level of AQP4 in STZ mice was nearly equal to that of normal mice. Li 2 CO 3 treatment did not exert any changes on the expression level of AQP4 in either normal or STZ mice.
DISCUSSION
The administration of STZ to mice causes an insulin deficiency by destroying b cells in the pancreas, leading to an increase in plasma glucose level and the presence of urine glucose. In addition, it has been reported that the presence of urine glucose causes polyuria, and subsequently, an increase in water intake. 23) Mice with severe diabetes were used in this study (Fig. 1) . The levels of plasma glucose and urine glucose in the Li 2 CO 3 treated STZ group were nearly the same as those in the STZ group (Figs. 1A, B) , but both urine volume and water intake increased significantly in the Li 2 CO 3 treated STZ group (Figs. 1C, D) . These findings indicated that Li 2 CO 3 was capable of increasing urine volume without exerting an effect on plasma glucose level.
Approximately 150 l of primary urine is generated per day by the human kidneys. This primary urine is re-absorbed at the proximal tubules, the descending limb of Henle's loop, the distal tubules, and the collecting tubules at levels of 65%, 15%, 15%, and 4%, respectively. In total, this system generates approximately 1.5 l of urine, which is excreted each day. The capacity for water re-absorption in the renal collecting duct is thought to determine urinary volume. 4) Thus, the urine volume depends on both the amount of primary urine generated and the volume of water re-absorption at the renal uriniferous tubules and collecting tubules. In this study, we calculated C cr values from the plasma and urinary creatinine concentrations to examine the generated volume of primary urine.
11) Based on these calculations, no change in C cr was observed after Li 2 CO 3 was administered to STZ mice (Fig.  1E ). This finding suggested that the volumes of primary urine were similar between Li 2 CO 3 -treated STZ mice and untreated STZ mice.
Recently, it has been revealed that AQP plays an important role in regulating urine volume. AQP1 is dominantly expressed in the renal cortex, including the proximal tubules, while AQP2, AQP3, and AQP4 are mainly expressed in the renal inner medulla, where the collecting tubules are dominantly present.
2) Vasopressin is known to regulate urinary volume via AQP2 and AQP3, expressed in the renal collecting duct. Vasopressin binds to the V 2 receptor expressed on the basolateral membranes of the renal collecting duct principal cells, which in turn activates AC. The cAMP produced by the activation of AC activates protein kinase A (PKA). 24, 25) The cAMP response element-binding protein (CREB) phosphorylation is mediated via the activation of PKA. 26, 27) The phosphorylation of CREB regulates the transcription and the expression level of AQP2 and AQP3. 28, 29) It is also known that the expression levels of AQP1 and AQP4 are not regulated by vasopressin. 30, 31) Increased secretion of vasopressin in diabetic patients and diabetic animals has also been reported. 32, 33) In this study, it was shown that the AQP2 and AQP3 levels of STZ mice were higher than those of normal mice, while the AQP1 and AQP4 levels of STZ mice were nearly equal to those of normal mice. These results were consistent with other reports, 30, 31) suggesting that urine concentration was controlled by vasopressin in the collecting tubules, not in the proximal tubules. In addition, the possibility was suggested that the increase of the urine volume by Li 2 CO 3 treatment was caused by reduced water re-absorption in the collecting tubules, not in the proximal tubules.
Water re-absorption in the collecting tubules depends on urinary osmotic pressure and AQP expression. 34, 35) To evaluate the urinary osmotic pressure in the collecting tubules, where final urine volume was determined, the mRNA expression levels of the osmoregulatory genes (SMIT and TauT) and transporters related to osmotic pressure were measured.
The levels of SMIT and TauT expression were enhanced along with the increase in osmotic pressure. [16] [17] [18] [19] The mRNA expressions of SMIT and TauT in the renal outer medulla were nearly the same between the STZ mice treated with Li 2 CO 3 and un-treated mice (Fig. 2) . This suggested that Li 2 CO 3 administration caused no change in the osmotic pressure in the renal collecting tubules.
The osmotic pressure in the collecting tubules is determined by sodium, urea, and glucose levels. The effects of Li 2 CO 3 treatment on sodium, urea, and glucose transporters were investigated. Li 2 CO 3 treatment caused no changes in the mRNA expression levels of sodium transporter (NKCC2), but significantly reduced the mRNA expression levels of urea transporter (UT-A1) and glucose transporters (GLUT2, SGLT2) (Fig. 3) . These results suggested the possibility that Li 2 CO 3 treatment did not change sodium re-absorption, but reduced urea and glucose re-absorption. Under the assumption that the volume of primary urine that reached the collecting tubules both in normal and STZ mice are the same with or without Li 2 CO 3 treatment, it was deduced that the urinary osmotic pressure of Li 2 CO 3 treated mice will decrease due to increased urine volume. However, in this study, SMIT and TauT did not change. These results suggested that one of the reasons why the increased urine volume that was induced by Li 2 CO 3 treatment did not affect the osmotic pressure in the collecting tubules was decreased urea and glucose re-absorption combined with unchanged sodium re-absorption. These results suggested that Li 2 CO 3 treatment did not change the osmotic pressure in the collecting tubules.
The expression levels of AQPs in the renal inner medulla, where the collecting tubules were dominantly present, were measured by the Western blotting method.
4) The expression levels of AQP2 and AQP3 in the plasma membrane fraction of the inner medulla in STZ mice were significantly higher than those of normal mice (Figs. 4B, C) . The expression levels of AQP2 and AQP3 in the plasma membrane fraction of the inner medulla were significantly decreased by Li 2 CO 3 treatment (Figs. 4B, C) . These results indicated that a decrease in the expression levels of AQP2 and AQP3 in the kidneys resulted in an increase in urine volume (Figs. 1C, 4B, C). It is known that AQPs transport water according to an osmotic gradient. 34, 35) In the kidneys, water is transported from the lumen to the blood vessels, because the osmotic pressure on the blood vessel side is always higher than the pressure inside the collecting tubules. 36) Therefore, this finding strongly suggests the possibility that increased expression levels of AQP2 and AQP3 in the renal collecting tubules play a role in promoting water re-absorption in the kidneys.
The urine volumes attributed to diabetic osmotic diuresis and to AQP2 and AQP3 were estimated as follows. The urine volume attributed to diabetic osmotic diuresis was calculated by determining the urine volume difference between two groups of mice that had different osmotic pressures but the same expression levels of AQP2 and AQP3 (difference between 0.2% Li 2 CO 3 -treated STZ mice and 0.2% Li 2 CO 3 -treated normal mice; Figs. 1C, 2, 4B, C) The urine volume attributed to diabetic osmotic diuresis deduced from the above calculation was roughly 63 ml. The urine volume attributed to AQP2 and AQP3 was calculated by determining the urine volume difference between two groups of mice that had the same osmotic pressures but different AQP2 and AQP3 levels (difference between 0.2% LI 2 CO 3 -treated STZ mice and un-treated STZ mice; Figs. 1C, 2, 4B, C) The urine volume attributed to AQP2 and AQP3 deduced from the above calculation was roughly 34 ml. From these results, the theoretical urine volume of STZ mice was calculated to be 30 ml [normal mice urine volume (1 ml)ϩ63 mlϪ34 ml], which closely approximated the observed value (36 ml). This result revealed that the increased levels of AQP2 and AQP3 in diabetics can play a role in alleviating dehydration.
Li 2 CO 3 has been used to treat manic-depression. It has been reported that hydrochlorothiazide, which is a diuretic, suppresses the AQP reduction in the kidneys of lithium-induced diabetes insipidus rats, and results in the improvement of diabetes insipidus. 37) However, in this study, the urine volume of Li 2 CO 3 -treated STZ mice was significantly higher than that of Li 2 CO 3 -treated normal mice (Fig. 1C) . This result indicates the possibility that Li 2 CO 3 may exacerbate polyuria in diabetic patients. Therefore, it is suggested that extra care should be taken when Li 2 CO 3 is used for diabetic patients.
A positive correlation between renal AQP2 expression and urine volume has been reported in polyuria due to diabetes, regardless of type (type I or type II). [5] [6] [7] The results of this study strongly suggest that the increased expression levels of AQP2 and AQP3 can promote the re-absorption of water and play a role as a compensatory mechanism to complement the reduction of water content in the body. In diabetes patients, although a significant decrease in body water due to polyuria has been a concern, there have been few actual cases of dehydration. We believe that this compensatory mechanism may play a role in preventing dehydration in polyuria associated with diabetes by increasing the expression levels of AQP2 and AQP3 in the kidneys.
